Send the following on WhatsApp
Continue to Chathttps://www.aifa.gov.it/web/guest/-/aggiornamento-schede-aifa-relative-a-idrossiclorochina-lopinavir-ritonavir-e-darunavir-cobicistat-nella-terapia-dei-pazienti-affetti-da-covid-19
https://www.aifa.gov.it/web/guest/-/aggiornamento-schede-aifa-relative-a-idrossiclorochina-lopinavir-ritonavir-e-darunavir-cobicistat-nella-terapia-dei-pazienti-affetti-da-covid-19